PMC:7199903 / 2848-3104 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T18","span":{"begin":143,"end":151},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T21","span":{"begin":210,"end":218},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T23","span":{"begin":38,"end":43},"obj":"http://purl.obolibrary.org/obo/BFO_0000029"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-Enju

    {"project":"LitCovid-sample-Enju","denotations":[{"id":"T462","span":{"begin":5,"end":10},"obj":"JJ"},{"id":"T463","span":{"begin":11,"end":18},"obj":"NN"},{"id":"T464","span":{"begin":19,"end":20},"obj":"-LRB-"},{"id":"T465","span":{"begin":20,"end":21},"obj":"CD"},{"id":"T466","span":{"begin":21,"end":22},"obj":"-RRB-"},{"id":"T467","span":{"begin":24,"end":37},"obj":"NN"},{"id":"T468","span":{"begin":38,"end":43},"obj":"NNS"},{"id":"T469","span":{"begin":44,"end":47},"obj":"VBP"},{"id":"T470","span":{"begin":48,"end":53},"obj":"IN"},{"id":"T471","span":{"begin":54,"end":63},"obj":"JJ"},{"id":"T472","span":{"begin":64,"end":72},"obj":"NN"},{"id":"T473","span":{"begin":73,"end":75},"obj":"IN"},{"id":"T474","span":{"begin":76,"end":80},"obj":"PRP"},{"id":"T475","span":{"begin":81,"end":91},"obj":"VBP"},{"id":"T476","span":{"begin":92,"end":98},"obj":"JJ"},{"id":"T477","span":{"begin":99,"end":106},"obj":"NN"},{"id":"T478","span":{"begin":107,"end":109},"obj":"IN"},{"id":"T479","span":{"begin":110,"end":119},"obj":"VBG"},{"id":"T480","span":{"begin":120,"end":128},"obj":"JJ"},{"id":"T481","span":{"begin":129,"end":137},"obj":"NNS"},{"id":"T482","span":{"begin":138,"end":142},"obj":"IN"},{"id":"T483","span":{"begin":143,"end":151},"obj":"NN"},{"id":"T484","span":{"begin":152,"end":166},"obj":"NN"},{"id":"T485","span":{"begin":168,"end":175},"obj":"RB"},{"id":"T486","span":{"begin":175,"end":176},"obj":"-COMMA-"},{"id":"T487","span":{"begin":177,"end":179},"obj":"PRP"},{"id":"T488","span":{"begin":180,"end":184},"obj":"VBP"},{"id":"T489","span":{"begin":185,"end":188},"obj":"DT"},{"id":"T490","span":{"begin":189,"end":192},"obj":"JJ"},{"id":"T491","span":{"begin":193,"end":201},"obj":"NN"},{"id":"T492","span":{"begin":202,"end":206},"obj":"NN"},{"id":"T493","span":{"begin":207,"end":209},"obj":"IN"},{"id":"T494","span":{"begin":210,"end":220},"obj":"NN"},{"id":"T495","span":{"begin":221,"end":224},"obj":"CC"},{"id":"T496","span":{"begin":225,"end":229},"obj":"IN"},{"id":"T497","span":{"begin":230,"end":232},"obj":"RB"},{"id":"T498","span":{"begin":233,"end":236},"obj":"RB"},{"id":"T499","span":{"begin":236,"end":237},"obj":"-COMMA-"},{"id":"T500","span":{"begin":238,"end":243},"obj":"EX"},{"id":"T501","span":{"begin":244,"end":248},"obj":"VBP"},{"id":"T502","span":{"begin":249,"end":253},"obj":"VBN"},{"id":"T503","span":{"begin":254,"end":256},"obj":"DT"}],"relations":[{"id":"R478","pred":"arg2Of","subj":"T481","obj":"T479"},{"id":"R479","pred":"arg1Of","subj":"T481","obj":"T480"},{"id":"R480","pred":"arg1Of","subj":"T481","obj":"T482"},{"id":"R481","pred":"arg2Of","subj":"T484","obj":"T482"},{"id":"R482","pred":"arg1Of","subj":"T484","obj":"T483"},{"id":"R483","pred":"arg1Of","subj":"T488","obj":"T485"},{"id":"R484","pred":"arg1Of","subj":"T488","obj":"T486"},{"id":"R460","pred":"arg1Of","subj":"T463","obj":"T462"},{"id":"R461","pred":"arg1Of","subj":"T463","obj":"T464"},{"id":"R462","pred":"arg2Of","subj":"T465","obj":"T464"},{"id":"R463","pred":"arg3Of","subj":"T466","obj":"T464"},{"id":"R464","pred":"arg1Of","subj":"T468","obj":"T467"},{"id":"R465","pred":"arg1Of","subj":"T468","obj":"T469"},{"id":"R466","pred":"arg2Of","subj":"T470","obj":"T469"},{"id":"R467","pred":"arg1Of","subj":"T468","obj":"T470"},{"id":"R468","pred":"arg2Of","subj":"T472","obj":"T470"},{"id":"R469","pred":"arg1Of","subj":"T472","obj":"T471"},{"id":"R470","pred":"arg1Of","subj":"T469","obj":"T473"},{"id":"R471","pred":"arg2Of","subj":"T475","obj":"T473"},{"id":"R472","pred":"arg1Of","subj":"T474","obj":"T475"},{"id":"R473","pred":"arg2Of","subj":"T477","obj":"T475"},{"id":"R474","pred":"arg1Of","subj":"T477","obj":"T476"},{"id":"R475","pred":"arg1Of","subj":"T475","obj":"T478"},{"id":"R476","pred":"arg2Of","subj":"T479","obj":"T478"},{"id":"R477","pred":"arg1Of","subj":"T474","obj":"T479"},{"id":"R485","pred":"arg1Of","subj":"T487","obj":"T488"},{"id":"R486","pred":"arg2Of","subj":"T495","obj":"T488"},{"id":"R487","pred":"arg1Of","subj":"T492","obj":"T489"},{"id":"R488","pred":"arg1Of","subj":"T492","obj":"T490"},{"id":"R489","pred":"arg1Of","subj":"T492","obj":"T491"},{"id":"R490","pred":"arg1Of","subj":"T492","obj":"T493"},{"id":"R491","pred":"arg2Of","subj":"T494","obj":"T493"},{"id":"R492","pred":"arg1Of","subj":"T492","obj":"T495"},{"id":"R493","pred":"arg2Of","subj":"T496","obj":"T495"},{"id":"R494","pred":"arg2Of","subj":"T502","obj":"T496"},{"id":"R495","pred":"arg1Of","subj":"T498","obj":"T497"},{"id":"R496","pred":"arg1Of","subj":"T502","obj":"T498"},{"id":"R497","pred":"arg1Of","subj":"T502","obj":"T499"},{"id":"R498","pred":"arg1Of","subj":"T500","obj":"T501"},{"id":"R499","pred":"arg2Of","subj":"T502","obj":"T501"},{"id":"R500","pred":"arg1Of","subj":"T500","obj":"T502"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-PD-FMA

    {"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T18","span":{"begin":143,"end":151},"obj":"Body_part"}],"attributes":[{"id":"A18","pred":"fma_id","subj":"T18","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-PD-NCBITaxon

    {"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T19","span":{"begin":210,"end":220},"obj":"Species"}],"attributes":[{"id":"A19","pred":"ncbi_taxonomy_id","subj":"T19","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T24","span":{"begin":24,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T19","span":{"begin":210,"end":220},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"108","span":{"begin":210,"end":220},"obj":"Species"}],"attributes":[{"id":"A108","pred":"pubann:denotes","subj":"108","obj":"Tax:2697049"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-PD-GO-BP-0

    {"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T14","span":{"begin":11,"end":18},"obj":"http://purl.obolibrary.org/obo/GO_0009606"},{"id":"T15","span":{"begin":24,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T16","span":{"begin":92,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0020012"},{"id":"T17","span":{"begin":92,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0051805"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sample-GO-BP

    {"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T13","span":{"begin":11,"end":18},"obj":"http://purl.obolibrary.org/obo/GO_0009606"},{"id":"T14","span":{"begin":24,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T15","span":{"begin":92,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0042783"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T14","span":{"begin":11,"end":18},"obj":"http://purl.obolibrary.org/obo/GO_0009606"},{"id":"T15","span":{"begin":24,"end":37},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T16","span":{"begin":92,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0042783"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T24","span":{"begin":24,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"108","span":{"begin":210,"end":220},"obj":"Species"}],"attributes":[{"id":"A108","pred":"tao:has_database_id","subj":"108","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ping viral tropism (9). Glycosylation sites are under selective pressure as they facilitate immune evasion by shielding specific epitopes from antibody neutralization. However, we note the low mutation rate of SARS-CoV-2 and that as yet, there have been no"}